Cost‐effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen‐detected Type 2 diabetes: analysis of the ADDITION‐UK cluster‐randomized controlled trial

By  

DIABETIC MEDICINE, Vol. 32, Iss. 7, 2015-07 ,pp. : 907-919

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study

By Janssen Paul GH   Gorter Kees J   Stolk Ronald P   Rutten Guy EHM  

British Journal of General Practice, Vol. 59, Iss. 558, 2009-01 ,pp. : 43-48

Royal College of General Practitioners

Access to resources Recommend Favorite

Intensive multifactorial treatment modifies the effect of family history of diabetes on glycaemic control in people with Type 2 diabetes: a post hoc analysis of the ADDITION‐Denmark randomized controlled trial

By  

DIABETIC MEDICINE, Vol. 32, Iss. 8, 2015-08 ,pp. : 1085-1089

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark

By Juul Lise   Sandbaek Annelli   Foldspang Anders   Frydenberg Morten   Borch-Johnsen Knut   Lauritzen Torsten  

Scandinavian Journal of Primary Health Care, Vol. 27, Iss. 4, 2009-12 ,pp. : 223-231

Informa Healthcare

Access to resources Recommend Favorite

Effect of six years intensified multifactorial treatment on levels of hs‐CRP and adiponectin in patients with screen detected type 2 diabetes: The ADDITION‐Netherlands randomized trial

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 1520-7552, Iss. 7, 2015-10 ,pp. : 758-766

John Wiley & Sons Inc

Access to resources Recommend Favorite